Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 454-463

  Damoiseaux, Jan ^a   Vaessen, M ^a   Knapen, Y ^a   Csernok, E ^b   Stegeman, C A ^c   Van Paassen, P ^a   Cohen Tervaert, J W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA; Glomerular basement membrane; Multiplex immunoassay; Myeloperoxidase; Proteinase 3

Indexed keywords

GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GOODPASTURE SYNDROME; HUMAN; IMMUNOASSAY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PREDICTION; SENSITIVITY AND SPECIFICITY; WEGENER GRANULOMATOSIS; ARTICLE; BIOPSY; BLOOD; GLOMERULONEPHRITIS; IMMUNOLOGY; KIDNEY; METHODOLOGY; RECURRENT DISEASE; VASCULITIS;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; KIDNEY; RECURRENCE; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 34848893970     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.051     Document Type: Conference Paper

References (17)

1. JENNETTE, J.C. & R.J. FALK. 1997. Small-vessel vasculitis. N. Engl. J. Med. 337: 1512-1523.
2. SAVIGE, J., D. GILLIS, E. BENSON, et al. 1999. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am. J. Clin. Pathol. 111: 507-513.
3. SAVIGE, J., W. DIMECH, M. FRITZLER, et al. 2003. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am. J. Clin. Pathol. 120: 312-318.
4. STEGEMAN, C.A. 2002. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 andmyeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Nephrol. Dial. Transplant. 17: 2077-2080.
5. RUTGERS, A., P. HEERINGA, J.G. DAMOISEAUX, et al. 2003. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur. J. Intern. Med. 14: 287-295.
6. STEGEMAN, C.A., J.W. COHEN TERVAERT, W.J. SLUITER, et al. 1994. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann. Intern. Med. 120: 12-17.
7. SLOT, M.C., J.W. COHEN TERVAERT, M.M. BOOMSMA, et al. 2004. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum. 51: 269-273.
8. BOOMSMA, M.M., C.A. STEGEMAN, M.J. VAN DER LEIJ, et al. 2000. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum. 43: 2025-2033.
9. RUTGERS, A., J. DAMOISEAUX, C. ROOZENDAAL, et al. 2004. ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J. Clin. Immunol. 24: 435-440.
10. DAMOISEAUX, J.G., M.C. SLOT, M. VAESSEN, et al. 2005. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANC-Aassociated vasculitis. J. Clin. Immunol. 25:202-208.
11. VILLALTA, D., E. TONUTTI, M. TAMPOIA, et al. 2004. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection. Clin. Chem. Lab. Med. 42: 1161-1167.
12. NIFLI, A.P., G. NOTAS, M. MAMOULAKI, et al. 2006. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J. Immunol. Methods 311: 189-197.
13. BINDER, S.R. 2006. Autoantibody detection using multiplex technologies. Lupus 15: 412-421.
14. CSERNOK, E., J. HOLLE, B. HELLMICH, et al. 2004. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxf.) 43: 174-180.
15. BOOMSMA, M.M., J.G. DAMOISEAUX, C.A. STEGEMAN, et al. 2003. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J. Immunol. Methods 274: 27-35.
16. VAN PAASSEN, P., P.J. VAN BREDA VRIESMAN, H. VAN RIE, et al. 2004. Signs and symptoms of thin basement membrane nephropathy: a prospective study on primary glomerular disease - The Limburg Renal Registry. Kidney Int. 66: 909-913.
17. HOLLE, J.U., B. HELLMICH, M. BACKES, et al. 2005. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off? Ann. Rheum. Dis. 64: 1773-1779.